SEC Form 4 · accession 0000874015-15-000006
IONIS PHARMACEUTICALS INC · IONS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stanley T Crooke
Officer — Chairman and CEO · Director
Period of report
Jan 2, 2015
Accepted (ET)
Jan 5, 2015 · 8:02 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874015
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 725,391 | I | By Trust |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $61.57 | Jan 2, 2015 | A | 165,000 | A | Jan 2, 2016 | Jan 1, 2022 | Common Stock | 165,000 | 165,000 | D |
| Employee Stock Option (right to buy)F2 | $61.57 | Jan 2, 2015 | M | 8,700 | A | Jan 2, 2016 | Jan 1, 2022 | Common Stock | 8,700 | 8,700 | I |
Explanation of responses
- F1Grant of 1/2/2015 to reporting person of stock options under the Isis Pharmacueticals, Inc. 2011 Equity Incentive Plan. 25% of the shares subject to the option vest and become exercisable on 1/2/2016. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 41,250 shares per year. The option was exercisable as to 0 on 1/2/2015.
- F2Grant of 1/2/2015 to reporting person of stock options under the Isis Pharmacueticals, Inc. 2011 Equity Incentive Plan. 25% of the shares subject to the option vest and become exercisable on 1/2/2016. Thereafter, the remaining shares subject to the option vest and become exercisable in 36 equal monthly installments, at the rate of 2,175 shares per year. The option was exercisable as to 0 on 1/2/2015.